SCHEMBL25503072

SCHEMBL25503072

C[C@@]1(C#N)COCc2ccc(C(=O)NCC(=O)Nc3nc(-c4cc(F)c5c(c4)OCO5)cs3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.40
▸ MEN1 O00255 8/20 0.40
▸ MAPT P10636 7/20 0.40
▸ LMNA P02545 6/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ RAB9A P51151 8/20 0.39
▸ NPC1 O15118 7/20 0.39
▸ SMN1; SMN2 Q16637 7/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HTT P42858 1/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ROCK1 Q13464 2/20 0.38
▸ PRKACA P17612 1/20 0.38
▸ NFKB1 P19838 2/20 0.37
▸ NFKB2 Q00653 2/20 0.37
▸ RELA Q04206 2/20 0.37
▸ GAA P10253 1/20 0.36
▸ CLK1 P49759 1/20 0.36
▸ CFTR P13569 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25503247 0.90 RAB9A (0.39) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25503254 0.88 MEN1 (0.38) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25502884 0.85 MAPT (0.44) KMT2AMEN1MAPTLMNARAB9A
SCHEMBL25502861 0.85 HDAC1 (0.46) KMT2AMEN1MAPTKDM4ERAB9A
SCHEMBL25503534 0.84 ALDH1A1 (0.41) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25503728 0.84 MEN1 (0.45) KMT2AMEN1MAPTKDM4ERAB9A
SCHEMBL25503398 0.82 MMP2 (0.37) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25503723 0.81 ALK (0.40) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25503734 0.81 CYP3A4 (0.47) KMT2AMEN1MAPTLMNAKDM4E
SCHEMBL25503748 0.81 ALDH1A1 (0.49) KMT2AMEN1MAPTLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149414-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB KMT2A 792/4885MEN1 1366/4885MAPT 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback